713465004: Dolutegravir sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Nucleotidyltransferase inhibitor\Integrase strand transfer inhibitor\Dolutegravir sodium
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Integrase strand transfer inhibitor\Dolutegravir sodium

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Integrase strand transfer inhibitor\Dolutegravir sodium

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Dolutegravir sodium

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Dolutegravir sodium
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Dolutegravir sodium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3297512018 Dolutegravir sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3297665018 Dolutegravir sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

807041000172112 dolutégravir sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dolutegravir sodium	Is a	Dolutegravir	false	Inferred relationship	Some
Dolutegravir sodium	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Integrase strand transfer inhibitor (disposition)	true	Inferred relationship	Some
Dolutegravir sodium	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Dolutegravir	true	Inferred relationship	Some
Dolutegravir sodium	Is a	Pyrimidine and/or pyrimidine derivative	true	Inferred relationship	Some
Dolutegravir sodium	Is a	Nucleotidyltransferase inhibitor	false	Inferred relationship	Some
Dolutegravir sodium	Is a	Integrase strand transfer inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dolutegravir (as dolutegravir sodium) 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	1
Product containing precisely dolutegravir (as dolutegravir sodium) 25 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	3
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	3
Product containing precisely dolutegravir (as dolutegravir sodium) 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	2
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolutegravir sodium	Inferred relationship	Some	2

This concept is not in any reference sets